Discontinuation report AURO-MONTELUKAST CHEWABLE TABLET
Report ID | 214593 |
Drug Identification Number | 02422867 |
Brand name | AURO-MONTELUKAST CHEWABLE TABLET |
Common or Proper name | AURO-MONTELUKAST CHEWABLE TABLET |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 4MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL |
Packaging size | 90's |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2023-12-29 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-12-30 | English | Compare |
v4 | 2023-12-29 | French | Compare |
v3 | 2023-12-29 | English | Compare |
v2 | 2023-12-29 | French | Compare |
v1 | 2023-12-29 | English | Compare |
Showing 1 to 5 of 5